Sfoglia per Autore
Improved Immune Reconstitution Following Pre-Emptive CD8-Depleted Donor Lymphocyte Infusions (DLIs) after Haploidentical Stem Cell Transplantation (SCT) Using a Reduced-Intensity Conditioning (RIC) Regimen
2005 P. Corradini, A. Raganato, M. Carrabba, L. Gandola, C. Lombardo, C. Carniti, L. Farina, R. Milani, A. Dodero
Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed
2005 A. Dodero, M. Carrabba, R. Milani, E. Rizzo, A. Raganato, V. Montefusco, L. Farina, M. Milanesi, P. Longoni, C. Carlo-Stella, P. Corradini
CD8-depleted donor lymphocyte infusions can boost immune reconstitution after haploidentical stem cell transplantation following reduced-intensity conditioning regimen
2006 P. Corradini, A. Raganato, C. Carniti, M. Carrabba, L. Farina, V. Montefusco, R. Milani, M. Milanesi, P. Longoni, E. Zorzan, L. Gandola, C. Lombardo, A. Dodero
Reduced intensity allogeneic stem cell transplantation is an effective salvage treatment for relapsed non-Hodgkin’s and Hodgkin’s lymphomas
2006 P. Corradini, A. Dodero, M. Bregni, A. Olivieri, P. Valagussa, L. Farina, R. Milani, R. Scime, A. Rambaldi, F. Bonifazi, F. Patriarca, A. Locasciulli, A. Bacigalupo, A. Gianni, C. Tarella
Pre-emptive CD8-depleted donor lymphocyte infusions to overcome long-lasting immune deficiency after haploidentical stem cell transplantation with a reduced intensity conditioning regimen
2006 P. Corradini, A. Raganato, M. Carrabba, C. Carniti, L. Farina, V. Montefusco, M. Milanesi, P. Longoni, E. Zorzan, L. Gandola, C. Lombardo, A. Dodero
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice
2006 C. Carlo-Stella, A. Guidetti, M. Di Nicola, P. Longoni, L. Cleris, C. Lavazza, M. Milanesi, R. Milani, M. Carrabba, L. Farina, F. Formelli, A.M. Gianni, P. Corradini
Pre-emptive CD8-depleted donor lymphocyte infusions to overcome long-lasting immune deficiency after haploidentical stem cell transplantation with a reduced-intensity conditioning regimen
2006 P. Corradini, A. Raganato, M. Carrabba, C. Carniti, L. Farina, V. Montefusco, M. Milanesi, P. Longoni, E. Zorzan, L. Gandola, C. Lombardo, A. Dodero
Molecular methods used for the detection of autologous graft contamination in lymphoid disorders
2007 P. Corradini, M. Carrabba, L. Farina
Qualitative and Quantitative PCR Monitoring of MRD: Practical Implications of a Surrogate Marker for GVL Effect after RIC Allogeneic Transplantation in Relapsed Chronic Lymphocytic Leukemia.
2007 L. Farina, C. Carniti, A. Dodero, A. Vendramin, A. Raganato, F. Patriarca, F. Narni, V. Montefusco, F. Benedetti, A. Olivieri, P. Corradini
Long-term outcome of ric-allo SCT for myeloma
2007 V. Montefusco, F. Ciceri, J. Peccatori, L. Farina, A. Oliveri, K. Aprile Hoenstaufen, G. Lambertenghi Deliliers, A.M. Gianni, M. Bregni, P. Corradini
Efficacy and safety of cytarabine-based regimens for mobilization of peripheral blood stem cells in multiple myeloma
2007 V. Montefusco, F. Spina, L. Farina, A. Dodero, F. Zallio, R. Milani, P. Corradini
Antibiotic prophylaxis before dental procedures can reduce ONJ incidence
2007 V. Montefusco, F. Gay, F. Spina, M.T. Ambrosini, M. Maniezzo, L. Farina, A. Miceli, A. Palumbo, M. Boccadoro, P. Corradini
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas : pre-transplant disease status and histotype heavily influence outcome
2007 P. Corradini, A. Dodero, L. Farina, R. Fanin, F. Patriarca, R. Miceli, P. Matteucci, M. Bregni, R. Scimé, F. Narni, E. Pogliani, A. Locasciulli, R. Milani, C. Carniti, A. Bacigalupo, A. Rambaldi, F. Bonifazi, A. Olivieri, A.M. Gianni, C. Tarella
Current role of allogeneic stem cell transplantation in follicular lymphoma
2007 L. Farina, P. Corradini
Hematopoietic stem cell transplantation in peripheral T-cell lymphomas
2007 P. Corradini, L. Farina, A. Dodero
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft
2008 L. Farina, B. Bruno, F. Patriarca, F. Spina, R. Sorasio, M. Morelli, R. Fanin, M. Boccadoro, P. Corradini
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft
2008 L. Farina, B. Bruno, F. Patriarca, F. Spina, R. Sorasio, M. Morelli, R. Fanin, M. Boccadoro, P. Corradini
Haemato-oncology and burnout : an Italian survey
2008 C. Bressi, S. Manenti, M. Porcellana, D. Cevales, L. Farina, I. Felicioni, G. Meloni, G. Milone, I.R. Miccolis, M. Pavanetto, L. Pescador, M. Poddigue, L. Scotti, A. Zambon, G. Corrao, G. Lambertenghi-Deliliers, G. Invernizzi
Qualitative and Quantitative PCR Monitoring of MRD : Practical Implications of a Surrogate Marker for GVL Effect after RIC Allogeneic Transplantation in Relapsed Chronic Lymphocytic Leukemia
2008 L. Farina, C. Carniti, A. Dodero, A. Vendramin, A. Raganato, F. Patriarca, F. Narni, V. Montefusco, F. Benedetti, A. Olivieri, P. Corradini
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft
2008 L. Farina, B. Bruno, F. Patriarca, F. Spina, R. Sorasio, M. Morelli, R. Fanin, M. Boccadoro, P. Corradini
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile